ADHD PreSMA Response Inhibition Therapy - Trial NCT06325813
Access comprehensive clinical trial information for NCT06325813 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Hospital Medical Center, Cincinnati and is currently Not yet recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Children's Hospital Medical Center, Cincinnati
Timeline & Enrollment
N/A
May 01, 2024
Dec 31, 2026
Primary Outcome
TMS-based Short-Interval Intracortical Inhibition (SICI),EEG-based beta activity,TMS-based Cortical Silent Period (cSP),EEG-based alpha activity
Summary
ADHD children have abnormal inhibitory control, meaning they have trouble stopping themselves
 from doing something they should not do. This ability to control involves an area in the
 brain called the pre-supplementary motor area (pre-SMA). Scientists have previously shown
 that the pre-SMA is abnormal in ADHD patients. In this study, we will use Transcranial
 Magnetic Stimulation (TMS) to stimulate the pre-SMA and determine the effects on measures
 that are related to inhibitory control.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06325813
Device Trial